Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat

Drug and Alcohol Dependence

Volumn 97, Issue 1-2, 2008, Pages 21-32

  Taracha, Ewa ^a   Chrapusta, Stanisław J ^b   Lehner, Małgorzata ^a   Skórzewska, Anna ^a   Maciejak, Piotr ^a,c   Szyndler, Janusz ^c   Płaźnik, Adam ^a,c  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cortex; Immediate early genes; Methadone; Morphine; Sensitization; Striatal complex

Indexed keywords

METHADONE; MORPHINE; PROTEIN FOS;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EXPOSURE; HEROIN DEPENDENCE; IMMUNOCHEMISTRY; INSULA; LOCOMOTION; MALE; MOTOR CORTEX; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SOMATOSENSORY CORTEX; THALAMUS MIDLINE NUCLEUS; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN CHEMISTRY; CEREBRAL CORTEX; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MALE; METHADONE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; NEOSTRIATUM; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 46649103436     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.03.013     Document Type: Article

References (70)

1. Aderjan R.E., and Skopp C. Formation and clearance of active and inactive metabolites of opiates in humans. Ther. Drug Monit. 20 (1998) 561-569
2. Ammon-Treiber S., and Höllt V. Morphine-induced changes of gene expression in the brain. Addict. Biol. 10 (2005) 81-89
3. Babbini M., and Davis W.M. Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br. J. Pharmacol. 46 (1972) 213-224
4. Babbini M., Gaiardi M., and Bartoletti M. Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment. Neuropharmacology 14 (1975) 611-614
5. Babbini M., Gaiardi M., and Bartoletti M. Dose-time motility effects of morphine and methadone in naive or morphinized rats. Pharmacol. Res. Commun. 11 (1979) 809-815
6. Badiani A., and Robinson T.E. Drug-induced neurobehavioral plasticity: role of environmental context. Behav. Pharmacol. 15 (2004) 327-339
7. Bartoletti M., Gaiardi M., Gebellini C., Bacchi A., and Nannini M. Previous treatment with morphine and sensitization to the excitatory actions of opiates: dose-effect relationship. Neuropharmacology 26 (1987) 115-119
8. B agonist reverses the behavioral sensitization to morphine in rats. Psychopharmacology 192 (2007) 79-85
9. Bisaga A., and Popik P. In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-d-aspartate (NMDA) antagonists. Drug Alcohol Depend. 59 (2000) 1-15
10. Bontempi B., and Sharp F.R. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by μ opioid receptors in the substantia nigra and ventral tegmental area. J. Neurosci. 17 (1997) 8596-8612
11. Cadoni C., and Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 90 (1999) 447-455
12. 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology 158 (2001) 259-266
13. Chang S.L., Squinto S.P., and Harlan R.E. Morphine activation of c-Fos expression in rat brain. Biochem. Biophys. Res. Commun. 157 (1988) 698-704
14. Curran E.J., Akil H., and Watson S.J. Psychomotor stimulant and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem. Res. 21 (1996) 1425-1435
15. D'Este L., Scontrini A., Casini A., Pontieri F.E., and Renda T.G. Heroin sensitization as mapped by c-Fos immunoreactivity in the rat striatum. Brain Res. 933 (2002) 144-149
16. Davis A.M., and Inturrisi C.E. d-Methadone blocks morphine tolerance and N-methyl-d-aspartate-induced hyperalgesia. J. Pharmacol. Exp. Ther. 289 (1999) 1048-1053
17. De Vries T.J., Schoffelmeer A.N., Binnekade R., Mulder A.H., and Vanderschuren L.J. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur. J. Neurosci. 10 (1998) 3565-3571
18. Di Chiara G., and North R.A. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13 (1992) 185-193
19. Eap C.B., Buclin T., and Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin. Pharmacokinet. 41 (2002) 1153-1193
20. Erdtmann-Vourliotis M., Mayer P., Riechert U., Grecksch G., and Höllt V. Identification of brain regions that are markedly activated by morphine in tolerant but not in naive rats. Mol. Brain Res. 61 (1998) 51-61
21. Ferguson S.M., Thomas M.J., and Robinson T.E. Morphine-induced c-fos mRNA expression in striatofugal circuits: modulation by dose, environmental context, and drug history. Neuropsychopharmacology 29 (2004) 1664-1674
22. Frankel P.S., Harlan R.E., and Garcia M.M. Chronic administration of morphine alters immediate-early gene expression in the forebrain of post-dependent rats. Brain Res. 835 (1999) 204-212
23. Gutstein H.B., Thome J.L., Fine J.L., Watson S.J., and Akil H. Pattern of c-fos m-RNA induction in rat brain by acute morphine. Can. Physiol. Pharmacol. 76 (1998) 294-303
24. Harlan R.E., and Garcia M.M. Drugs of abuse and immediate-early genes in the forebrain. Mol. Neurobiol. 16 (1998) 221-267
25. He S.T., and Grasing K. Chronic opiate treatment enhances both cocaine-reinforced and cocaine-seeking behaviors following opiate withdrawal. Drug Alcohol Depend. 75 (2007) 215-221
26. He L., and Whistler J.L. An opiate cocktail that reduces morphine tolerance and dependence. Curr. Biol. 15 (2005) 1028-1033
27. Ikemoto M., Takita M., Imamura T., and Inoue K. Increased sensitivity to the stimulant effects of morphine conferred by anti-adhesive glycoprotein SPARC in amygdala. Nature Med. 6 (2000) 910-915
28. Inturrisi C.E. Pharmacology of methadone and its isomers. Minerva Anestesiol. 71 (2005) 435-437
29. Johnson S.W., and North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12 (1992) 483-488
30. Kalinichev M., White D.A., and Holtzman S.G. Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitisation. Psychopharmacology 177 (2004) 61-67
31. Kornetsky C. Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse. Neurosci. Biobehav. Rev. 27 (2004) 777-786
32. Kreek M.J. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann. N. Y. Acad. Sci. 909 (2000) 186-216
33. Kreek M.J., and Vocci F.J. History and current status of opioid maintenance treatments: blending conference session. J. Subst. Abuse Treat. 23 (2002) 93-105
34. Laugwitz K.L., Offermanns S., Spicher K., and Schultz G. μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron 10 (1993) 233-242
35. Le Moal M., and Koob G.F. Drug addiction: pathways to the disease and pathophysiological perspectives. Eur. Neuropsychopharmacol. 17 (2007) 377-393
36. Lehner M., Taracha E., Skorzewska A., Maciejak P., Wislowska-Stanek A., Zienowicz M., Szyndler J., Bidzinski A., and Plaznik A. Behavioral, immunocytochemical and biochemical studies in rats differing in their sensitivity to pain. Behav. Brain Res. 171 (2006) 189-198
37. Ling G.S., Umans J.G., and Inturrisi C.E. Methadone: radioimmunoassay and pharmacokinetics in the rat. J. Pharmacol. Exp. Ther. 217 (1981) 147-151
38. 1 and N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. USA 91 (1994) 8537-8541
39. Madlung E., Haring C., Crespo J.A., Saria A., Grubinger P., and Zernig G. Methadone doses upon multiple readmissions to inpatient detoxification: clinical evidence for very moderate opioid tolerance. Pharmacology 78 (2006) 38-43
40. Magalas Z., De Vry J., and Tzschentke T.M. The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous selfadministration of heroin in rats. Eur. J. Pharmacol. 528 (2005) 103-109
41. Martin T.J., Kahn W.R., Xiao R., and Childers S.R. Differential regional effects of methadone maintenance compared to heroin dependence on μ-opioid receptor desensitization in rat brain. Synapse 61 (2007) 176-184
42. Mendez I.A., and Trujillo K.A. NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats. Psychopharmacology 196 (2008) 497-509
43. Murphy C.A., Russig H., Pezze M.A., Ferger B., and Feldon J. Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: effects of different schedules of administration. Neuropharmacology 44 (2003) 926-939
44. Murray F., Harrison N.J., Grimwood S., Bristow L.J., and Hutson P.H. Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats. Eur. J. Pharmacol. 562 (2007) 191-197
45. Nestby P., Vanderschuren L.J., De Vries T.J., Hogenboom F., Wardeh G., Mulder A.H., and Schoffelmeer A.N. Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization. Psychopharmacology 133 (1997) 69-76
46. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25 (2004) 210-218
47. Obernier J.A., and Baldwin R.L. Establishing an appropriate period of acclimatization following transportation of laboratory animals. ILAR J. 47 (2006) 364-369
48. Paolone G., Conversi D., Caprioli D., Del Bianco P., Nencini P., Cabib S., and Badiani A. Modulatory effect of environmental context and drug history on heroin-induced psychomotor activity and Fos protein expression in the rat brain. Neuropsychopharmacology 32 (2007) 2611-2623
49. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1998), Academic Press, San Diego
50. Piepponen T.P., Mikkola J.A.V., Ruotsalainen M., Jonker D., and Ahtee L. Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration. Br. J. Pharmacol. 127 (1999) 268-274
51. Pollock J., and Kornetsky C. Reexpression of morphine oral stereotypy six months after last morphine sensitizing dose. Pharmacol. Biochem. Behav. 53 (1996) 67-71
52. Pontieri F.E., Calo L., Di Grezia R., Orzi F., and Passarelli F. Functional correlates of heroin sensitization in the rat brain. Eur. J. Pharmacol. 335 (1997) 133-137
53. Popik P., Wróbel M., and Bisaga A. Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology 31 (2006) 160-170
54. Raith K., and Hochhaus G. Drugs used in the tratment of opioid tolerance and physical dependence. A review. Int. J. Clin. Pharmacol. Ther. 42 (2004) 191-203
55. Ryabinin A.E., Melia K.R., Cole M., Bloom F.E., and Wilson M.C. Alcohol selectively attenuates stress-induced c-fos expression in rat hippocampus. J. Neurosci. 15 (1995) 721-730
56. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1988) 1328-1331
57. 1 receptors mediate induction of c-fos and junB genes in striatum following morphine administration: implications for studies of memory. Behav. Brain Res. 66 (1995) 225-230
58. Siegel S., and Castellan Jr. N.J. Nonparametric Statistics for the Behavioral Sciences. second ed. (1988), McGraw-Hill Inc., New York pp. 213-215
59. Steffensen S.C., Stobbs S.H., Colago E.E., Lee R.S., Koob G.F., and Gallegos R.A. Contingent and noncontingent effects of heroin on μ-opioid receptor-containing ventral tegmental area GABA neurons. Exp. Neurol. 202 (2006) 139-151
60. Stewart J., and Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4 (1993) 289-312
61. Subhan F., Pache D.M., and Sewell R.D.E. Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetine. Eur. J. Pharmacol. 390 (2000) 137-143
62. Taracha E., Habrat B., Chmielewska K., and Baran-Furga H. Excretion profile in dependent patients in relation to route of administration and type of drug measured in urine with immunoassay. J. Anal. Toxicol. 29 (2005) 19-21
63. Taracha E., Lehner M., Wisłowska-Stanek A., Zienowicz M., Maciejak P., Bidziński A., Skórzewska A., Turzyńska D., and Płaźnik A. Effects of methadone and morphine on c-Fos expression in the rat brain: similarities and differences. Pharmacol. Rep. 58 (2006) 120-124
64. Trujillo K.A., Kubota K.S., and Warmoth K.P. Continuous administration of opioids produces locomotor sensitization. Pharmacol. Biochem. Behav. 79 (2004) 661-669
65. Turchan J., Maj M., and Przewłocka B. The effects of drugs of abuse on NMDAR1 receptor expression in the rat limbic systems. Drug Alcohol Depend. 72 (2003) 193-196
66. Vanderschuren L.J.M.J., Tjon G.H.K., Nestby P., Mulder A.H., Schoffelmeer A.N.M., and De Vries T.J. Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of pretreatment regimen. Psychopharmacology 131 (1997) 115-122
67. Vanderschuren L.J.M.J., De Vries T.J., Wardeh G., Hogenboom F.A.C.M., and Schoffelmeer A.N.M. A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur. J. Neurosci. 14 (2001) 1533-1538
68. Ward S.J., Lack C., Morgan D., and Roberts D.C. Discrete-trials heroin self-administration produces sensitization to the reinforcing effects of cocaine in rats. Psychopharmacology 185 (2006) 150-159
69. A receptor agents. Behav. Pharmacol. 18 (2007) 303-310
70. Zernig G., Wakonigg G., Madlung E., Haring C., and Saria A. Do vertical shifts in dose response rate-relationships in operant conditioning procedures indicate "sensitization" to "drug wanting"?. Psychopharmacology 171 (2004) 349-351